Cargando…

No significant viral transcription detected in whole breast cancer transcriptomes

BACKGROUND: Studies evaluating the presence of viral sequences in breast cancer (BC), including various strains of human papillomavirus and human herpes virus, have yielded conflicting results. Most were based on RT-PCR and in situ hybridization. METHODS: In this report we searched for expressed vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fimereli, Danai, Gacquer, David, Fumagalli, Debora, Salgado, Roberto, Rothé, Françoise, Larsimont, Denis, Sotiriou, Christos, Detours, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374178/ https://www.ncbi.nlm.nih.gov/pubmed/25884932 http://dx.doi.org/10.1186/s12885-015-1176-2

Ejemplares similares

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome
por: Fumagalli, Debora, et al.
Publicado: (2015)

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology
por: Fumagalli, Debora, et al.
Publicado: (2014)

TriageTools: tools for partitioning and prioritizing analysis of high-throughput sequencing data
por: Fimereli, Danai, et al.
Publicado: (2013)

Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
por: Venet, David, et al.
Publicado: (2020)

Transcriptional output, cell-type densities, and normalization in spatial transcriptomics
por: Saiselet, Manuel, et al.
Publicado: (2020)

Timing evolution of lobular breast cancer through phylogenetic analysis
por: Fimereli, Danai, et al.
Publicado: (2022)

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays
por: Jose, Vinu, et al.
Publicado: (2018)

New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer
por: Saiselet, Manuel, et al.
Publicado: (2015)

miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers
por: Saiselet, Manuel, et al.
Publicado: (2016)

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
por: Agostinetto, Elisa, et al.
Publicado: (2021)

Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis
por: Azim, Hatem A., et al.
Publicado: (2013)

Correction: Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis
por: Azim, Hatem A., et al.
Publicado: (2013)

Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients
por: Rothé, Françoise, et al.
Publicado: (2021)

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial
por: Sonnenblick, Amir, et al.
Publicado: (2015)

Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach
por: Bareche, Yacine, et al.
Publicado: (2019)

Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer
por: Nguyen, Bastien, et al.
Publicado: (2019)

ESR1 mutations in metastatic lobular breast cancer patients
por: Desmedt, Christine, et al.
Publicado: (2019)

Uncovering the genomic heterogeneity of multifocal breast cancer
por: Desmedt, Christine, et al.
Publicado: (2015)

Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer
por: Tarabichi, M, et al.
Publicado: (2015)

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer
por: Sonnenblick, Amir, et al.
Publicado: (2015)

Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
por: Venet, David, et al.
Publicado: (2011)

A fuzzy gene expression-based computational approach improves breast cancer prognostication
por: Haibe-Kains, Benjamin, et al.
Publicado: (2010)

CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib
por: Raspé, Eric, et al.
Publicado: (2017)

Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation
por: Suzuki, Ikuo K., et al.
Publicado: (2018)

HER2-Positive Circulating Tumor Cells in Breast Cancer
por: Ignatiadis, Michail, et al.
Publicado: (2011)

Immune Infiltration in Invasive Lobular Breast Cancer
por: Desmedt, Christine, et al.
Publicado: (2018)

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial
por: De Caluwé, Alex, et al.
Publicado: (2021)

Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma
por: Esmeray Sönmez, Esra, et al.
Publicado: (2022)

Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
por: Brown, David, et al.
Publicado: (2017)

Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
por: Brown, David, et al.
Publicado: (2017)

Genes Expressed in Specific Areas of the Human Fetal Cerebral Cortex Display Distinct Patterns of Evolution
por: Lambert, Nelle, et al.
Publicado: (2011)

Sensitive Detection of Viral Transcripts in Human Tumor Transcriptomes
por: Schelhorn, Sven-Eric, et al.
Publicado: (2013)

A research note regarding "Variation in cancer risk among tissues can be explained by the number of stem cell divisions"
por: Tarabichi, Maxime, et al.
Publicado: (2016)

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges
por: Wang, Xiaoxiao, et al.
Publicado: (2023)

Digital analysis of distant and cancer-associated mammary adipocytes
por: Isnaldi, Edoardo, et al.
Publicado: (2020)

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
por: Toussaint, Jérôme, et al.
Publicado: (2009)

Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)
por: Toussaint, Jérôme, et al.
Publicado: (2010)

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
por: Hunter, Francis W., et al.
Publicado: (2019)

Clinico-pathological and transcriptomic determinants of SLFN11 expression in invasive breast carcinoma
por: Zoppoli, Gabriele, et al.
Publicado: (2015)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
por: Maetens, Marion, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rq62t9ka5g85iuf0dcf1vnpnla